Haduvio™|Trevi Therapeutics (2024)

The cause of chronic cough is thought to be the result of a hypersensitivity disorder where a stimulus, either chemical or mechanical, sends a message to the brain, through the brainstem, resulting in a cough. It is believed that IPF patients have an increased sensitivity to cough stimuli resulting in chronic cough. Since kappa and mu receptors are found in the respiratory regions of the brain, brainstem, lungs, and peripheral lung nerves, it is hypothesized that Haduvio can block the cough signal centrally and as well as peripherally and result in cough reduction independent of the initial stimuli.

Haduvio™|Trevi Therapeutics (1)

Due to its dual mechanism of action (MOA), we believeHaduviois well suited to address chronic cough across a variety of conditions.

For more information on our global clinical development programs, please visit our Pipeline page.

Haduvio™|Trevi Therapeutics (2)

Haduvio™|Trevi Therapeutics (2024)
Top Articles
Latest Posts
Article information

Author: Horacio Brakus JD

Last Updated:

Views: 6052

Rating: 4 / 5 (51 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Horacio Brakus JD

Birthday: 1999-08-21

Address: Apt. 524 43384 Minnie Prairie, South Edda, MA 62804

Phone: +5931039998219

Job: Sales Strategist

Hobby: Sculling, Kitesurfing, Orienteering, Painting, Computer programming, Creative writing, Scuba diving

Introduction: My name is Horacio Brakus JD, I am a lively, splendid, jolly, vivacious, vast, cheerful, agreeable person who loves writing and wants to share my knowledge and understanding with you.